Clinical Trial Update: Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing empirical meropenem versus piperacillin/tazobactam in adults with sepsis (including septic shock) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Meropenem (Meropenem)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Scandinavian Critical Care Trials Group | Conditions: Sepsis, Septic Shock | Phase 4 | Status: RECRUITING